Guilherme Harada

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Locally Advanced

Cerebrospinal Fluid

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Cancer research communications

Cancer discovery

JCO precision oncology

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors. Cancer discovery (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC. Cancer research communications (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J Falcon, Patrick Evans, Josephine Feliciano, Christine L Hann, David S Ettinger, Kellie N Smit, Valsamo Anagnostou, Patrick M Forde, Julie R Brahmer, Benjamin Levy, Alexander E Drilon, Vincent K Lam
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC. Cancer research communications 4 (3) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, Matteo Repetto, Melissa S Gildenberg, Ankit Singh, Yvonne Y Li, Andréanne Gagné, Xinan Wang, Ayal A Aizer, Kelly N Fitzgerald, Mizuki Nishino, Joao M Victor Alessi, Federica Pecci, Alessandro Di Federico, Adam S Fisch, Alexander E Drilon, Valentina Nardi, Lynette M Sholl, Mark M Awad, Julia Rotow
Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib. JCO precision oncology 7 (2023)
Guilherme Harada, Soo-Ryum Yang, Emiliano Cocco, Alexander E Drilon
Rare molecular subtypes of lung cancer. Nature reviews. Clinical oncology 20 (4) (2023)
Julia Rotow, Jyoti D Patel, Matthew P Hanley, Helena Alexandra Yu, Mark M Awad, Jonathan Wade Goldman, Hovav Nechushtan, Matthias Scheffler, Allen Chung-Cheng Huang, Senthil Rajappa, Guilherme Harada, Sarah Clifford, Alison D Santucci, Laura Silva, Rebecca Tupper, Geoffrey R Oxnard, Jennifer Kherani, Alexander E Drilon
Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Guilherme Harada, Soo-Ryum Yang, Emiliano Cocco, Alexander E Drilon
Rare molecular subtypes of lung cancer. Nature reviews. Clinical oncology (2023)
Yonina R Murciano-Goroff, Guilherme Harada, Alexander E Drilon
An Ascendant Challenge: Central Nervous System Metastases in ALK+ Lung Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Margherita Ambrosini, Marzia Del Re, Francesco Pantano, Andrew E Hendifar, Alexander E Drilon, Guilherme Harada, Anne Hansen Ree, Samuel J Klempner, Gunhild Mari Mælandsmo, Norman John Carr, Hege G Russnes, James M Cleary, Harshabad Singh, Elisa Sottotetti, Antonia Martinetti, Giovanni Randon, Andrea Sartore-Bianchi, Iolanda Capone, Massimo Milione, Maria Di Bartolomeo, Filippo Pietrantonio
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series. JCO precision oncology 6 (2022)
Guilherme Harada, Maria Fernanda Batistuzzo Vicentini Neffa, Renata Colombo Bonadio, Elizabeth Zambrano Mendoza, Rafael Caparica, Letícia Leone Lauricella, Teresa Yae Takagaki, Felipe Santa Rosa Roitberg, Ricardo Mingarini Terra, Gilberto de Castro Junior
Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 47 (3) (2021)
Guilherme Harada, Renata Rodrigues da Cunha Colombo Bonadio, Frederico Cantarino Cordeiro de Araújo, Carolina Ribeiro Victor, Rubens Antonio Aissar Sallum, Ulysses Ribeiro Junior, Ivan Cecconello, Flávio Roberto Takeda, Tiago Biachi de Castria
Induction Chemotherapy for Locally Advanced Esophageal Cancer. Journal of gastrointestinal cancer 51 (2) (2021)
Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, Artur Katz, Rodrigo Ramella Munhoz
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy. Immunotherapy 12 (15) (2020)
Gilberto de Castro Junior, Guilherme Harada, Evandro Sobroza de Mello
The importance of molecular characterization in lung cancer. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 45 (3) (2019)